Eugenio Maria Mercuri
← Back to Università Cattolica del Sacro Cuore
Università Cattolica del Sacro Cuore
Eugenio Maria Mercuri works in Neurogenetic and Muscular Disorders Research, Muscle Physiology and Disorders, Amyotrophic Lateral Sclerosis Research, Lysosomal Storage Disorders Research, Genomics and Rare Diseases. Recorded institutional associations include Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Centro Clinico Nemo.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
2017 · 2,319 citationsNusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
2018 · 1,428 citationsDuchenne muscular dystrophy
2021 · 1,312 citationsDiagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
2017 · 1,055 citationsDiagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics
2017 · 684 citationsOrigin and timing of brain lesions in term infants with neonatal encephalopathy
2003 · 606 citationsMutations in the Fukutin-Related Protein Gene (FKRP) Cause a Form of Congenital Muscular Dystrophy with Secondary Laminin α2 Deficiency and Abnormal Glycosylation of α-Dystroglycan
2001 · 603 citationsSpinal muscular atrophy
2011 · 577 citationsMuscular dystrophies
2019 · 551 citationsLongitudinal effect of eteplirsen versus historical control on ambulation in D uchenne muscular dystrophy
2015 · 518 citationsClinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene
2000 · 502 citationsAtaluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2017 · 452 citationsRefining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan
2007 · 441 citationsMuscle MRI in inherited neuromuscular disorders: Past, present, and future
2007 · 439 citationsRisdiplam in Type 1 Spinal Muscular Atrophy
2021 · 436 citationsMuscular dystrophies
2013 · 434 citationsSpinal muscular atrophy
2022 · 430 citationsAtaluren treatment of patients with nonsense mutation dystrophinopathy
2014 · 428 citationsChildhood spinal muscular atrophy: controversies and challenges
2012 · 423 citationsAbnormal Magnetic Resonance Signal in the Internal Capsule Predicts Poor Neurodevelopmental Outcome in Infants With Hypoxic-Ischemic Encephalopathy
1998 · 394 citationsThe Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability
2010 · 391 citationsOptimality score for the neurologic examination of the infant at 12 and 18 months of age
1999 · 384 citationsRevised upper limb module for spinal muscular atrophy: Development of a new module
2016 · 347 citationsNeurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations
2015 · 332 citationsIncreased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
2020 · 332 citations
